载脂蛋白A1抗体Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Apolipoprotein A I promotes cholesterol efflux from tissues to the liver for excretion. Apolipoprotein A I is the major protein component of high density lipoprotein (HDL) in the plasma. Synthesized in the liver and small intestine, 载脂蛋白A1抗体it consists of two identical chains of 77 amino acids; an 18 amino acid signal peptide is removed co-translationally and a 6 amino acid propeptide is cleaved post-translationally. Apolipoprotein A I is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. Defects in the Apolipoprotein A I gene are associated with HDL 载脂蛋白A1抗体deficiency and Tangier disease. The therapeutic potential of apoA-I has been recently assessed in patients with acute coronary syndromes, using a recombinant form of a naturally occurring variant of apoA-I. The availability of recombinant normal apoA-I should facilitate further investigation into the potential usefulness of apoA-I in preventing atherosclerotic vascular diseases.
载脂蛋白A1抗体Also known as:
AI BP; AIBP; ApoA I binding protein; Apolipoprotein A I; Apolipoprotein A 1; Apo AI; ApoA I; APOA1; APOA1/APOC3 fusion gene; Apo A1; Apo-A1; Apolipoprotein A I precursor; Apolipoprotein A I binding protein; Apolipoprotein AI; Apolipoprotein of high density lipoprotein; ApolipoproteinAI; Brp14; Ltw1; Lvtw1; MGC117399; MGC119143; MGC119144; MGC119145; NAD(P)H hydrate epimerase; NAD(P)HX epimerase; YjeF N terminal domain containing protein 1; yjeF_N1; YJEFN1; APOA1_HUMAN; Sep1; Sep2.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated synthetic peptide derived from human APOA1.
●
Predicted Molecular Weight: 27kDa.
载脂蛋白A1抗体Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl705Bo01粘蛋白2(MUC2)多克隆抗体Polyclonal Antibody to Mucin 2 (MUC2)
kl413Hu01粘蛋白1(MUC1)多克隆抗体Polyclonal Antibody to Mucin 1 (MUC1)
kl413Mu01粘蛋白1(MUC1)多克隆抗体Polyclonal Antibody to Mucin 1 (MUC1)
kl413Ra01粘蛋白1(MUC1)多克隆抗体Polyclonal Antibody to Mucin 1 (MUC1)
kl413Bo01粘蛋白1(MUC1)多克隆抗体Polyclonal Antibody to Mucin 1 (MUC1)
kl697Hu01α1-抗胰蛋白酶(α1AT)多克隆抗体Polyclonal Antibody to Alpha-1-Antitrypsin (a1AT)
kl697Mu01α1-抗胰蛋白酶(α1AT)多克隆抗体Polyclonal Antibody to Alpha-1-Antitrypsin (a1AT)
kl697Ra01α1-抗胰蛋白酶(α1AT)多克隆抗体Polyclonal Antibody to Alpha-1-Antitrypsin (a1AT)
kl817Hu01结合珠蛋白(Hpt)多克隆抗体Polyclonal Antibody to Haptoglobin (Hpt)
kl817Mu01结合珠蛋白(Hpt)多克隆抗体Polyclonal Antibody to Haptoglobin (Hpt)
kl817Ra01结合珠蛋白(Hpt)多克隆抗体Polyclonal Antibody to Haptoglobin (Hpt)
kl817Gu01结合珠蛋白(Hpt)多克隆抗体Polyclonal Antibody to Haptoglobin (Hpt)
kl817Rb53结合珠蛋白(Hpt)多克隆抗体Polyclonal Antibody to Haptoglobin (Hpt)
kl236Hu01纤溶酶原(Plg)多克隆抗体Polyclonal Antibody to Plasminogen (Plg)
kl236Mu01纤溶酶原(Plg)多克隆抗体Polyclonal Antibody to Plasminogen (Plg)
kl236Ra01纤溶酶原(Plg)多克隆抗体Polyclonal Antibody to Plasminogen (Plg)
kl017Hu01α2-巨球蛋白(α2M)多克隆抗体Polyclonal Antibody to Alpha-2-Macroglobulin (a2M)
kl017Mu01α2-巨球蛋白(α2M)多克隆抗体Polyclonal Antibody to Alpha-2-Macroglobulin (a2M)
kl017Ra01α2-巨球蛋白(α2M)多克隆抗体Polyclonal Antibody to Alpha-2-Macroglobulin (a2M)
kl780Hu01乳铁传递蛋白(LTF)多克隆抗体Polyclonal Antibody to Lactoferrin (LTF)
kl780Mu01乳铁传递蛋白(LTF)多克隆抗体Polyclonal Antibody to Lactoferrin (LTF)
kl780Ra01乳铁传递蛋白(LTF)多克隆抗体Polyclonal Antibody to Lactoferrin (LTF)
kl667Hu01葡萄糖激酶(GCK)多克隆抗体Polyclonal Antibody to Glucokinase (GCK)
kl667Mu01葡萄糖激酶(GCK)多克隆抗体Polyclonal Antibody to Glucokinase (GCK)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话